Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Thyroid (All Stages^), 2016-2020

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by CI*Rank
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Recent Trend
Recent 5-Year Trend in Incidence Rates
(95% Confidence Interval)
 sort by trend descending
US (SEER+NPCR) 1 13.3 (13.2, 13.3) N/A 44,551 falling falling trend -2.3 (-3.4, -1.5)
New York 7 18.3 (18.1, 18.6) 1 (1, 2) 3,820 falling falling trend -1.5 (-3.3, -0.4)
New Jersey 7 17.5 (17.1, 17.9) 2 (2, 5) 1,673 falling falling trend -2.2 (-4.0, -0.8)
Pennsylvania 6 17.1 (16.8, 17.4) 3 (2, 7) 2,366 falling falling trend -3.4 (-4.7, -2.6)
West Virginia 6 16.6 (15.8, 17.5) 4 (2, 12) 329 stable stable trend 1.1 (-3.5, 3.4)
North Dakota 6 16.5 (15.2, 17.9) 5 (1, 17) 124 stable stable trend -1.4 (-9.4, 4.2)
Massachusetts 7 16.5 (16.1, 16.9) 6 (3, 11) 1,233 falling falling trend -6.0 (-9.8, -1.7)
Utah 7 16.4 (15.7, 17.1) 7 (2, 12) 476 falling falling trend -2.3 (-4.6, -0.6)
Rhode Island 6 16.2 (15.1, 17.3) 8 (2, 16) 186 falling falling trend -2.5 (-6.5, -0.2)
Connecticut 7 16.2 (15.6, 16.8) 9 (3, 12) 622 falling falling trend -4.3 (-7.8, -1.9)
Delaware 6 15.8 (14.7, 17.0) 10 (2, 19) 165 stable stable trend -3.5 (-9.4, 2.7)
Nebraska 6 15.8 (15.0, 16.7) 11 (3, 16) 310 stable stable trend 1.8 (-0.3, 2.7)
Wyoming 6 15.0 (13.6, 16.5) 12 (3, 28) 89 rising rising trend 2.0 (0.6, 3.6)
New Mexico 7 14.8 (14.1, 15.6) 13 (9, 23) 326 rising rising trend 1.9 (0.3, 2.8)
South Dakota 6 14.8 (13.6, 16.0) 14 (5, 27) 130 rising rising trend 3.6 (2.4, 5.0)
Kansas 6 14.7 (14.0, 15.3) 15 (10, 23) 438 falling falling trend -3.1 (-5.7, -1.2)
Ohio 6 14.7 (14.3, 15.0) 16 (11, 20) 1,817 stable stable trend -0.8 (-2.2, 0.4)
Kentucky 7 14.6 (14.1, 15.1) 17 (11, 22) 691 falling falling trend -3.6 (-5.8, -1.8)
Iowa 7 14.1 (13.5, 14.8) 18 (12, 26) 460 stable stable trend 1.3 (-3.6, 3.2)
Maine 6 14.1 (13.2, 15.0) 19 (11, 28) 215 stable stable trend -3.7 (-13.6, 2.2)
Vermont 6 14.0 (12.7, 15.4) 20 (8, 36) 95 stable stable trend 1.0 (-1.3, 2.1)
Louisiana 7 14.0 (13.5, 14.5) 21 (14, 26) 686 rising rising trend 1.6 (0.3, 2.7)
Idaho 7 13.7 (12.9, 14.5) 22 (13, 31) 244 falling falling trend -2.5 (-3.9, -1.2)
Montana 6 13.6 (12.6, 14.6) 23 (12, 36) 154 stable stable trend -1.1 (-4.3, 0.5)
Colorado 6 13.6 (13.1, 14.0) 24 (18, 28) 810 falling falling trend -2.6 (-4.1, -1.3)
New Hampshire 6 13.4 (12.5, 14.3) 25 (14, 35) 200 falling falling trend -5.3 (-12.3, -0.2)
Illinois 7 13.3 (13.0, 13.6) 26 (21, 29) 1,797 falling falling trend -4.2 (-7.0, -2.2)
Hawaii 7 13.2 (12.4, 14.1) 27 (16, 37) 200 falling falling trend -3.0 (-5.2, -1.2)
Wisconsin 6 13.2 (12.8, 13.6) 28 (21, 31) 819 stable stable trend -0.8 (-2.9, 0.6)
Maryland 6 12.6 (12.2, 13.0) 29 (26, 37) 812 falling falling trend -3.5 (-5.4, -2.0)
California 7 12.6 (12.4, 12.7) 30 (27, 34) 5,178 stable stable trend -0.5 (-1.5, 0.5)
Oregon 6 12.6 (12.1, 13.1) 31 (25, 38) 566 stable stable trend -1.7 (-4.6, 0.4)
Florida 6 12.3 (12.1, 12.6) 32 (29, 37) 2,901 stable stable trend -0.8 (-2.8, 1.1)
Minnesota 6 12.3 (11.9, 12.7) 33 (28, 40) 717 stable stable trend -1.3 (-4.4, 1.2)
Washington 5 12.2 (11.8, 12.5) 34 (29, 40) 972 falling falling trend -2.0 (-3.2, -1.1)
Oklahoma 6 12.2 (11.7, 12.7) 35 (27, 42) 493 stable stable trend -1.4 (-5.5, 1.4)
Arizona 6 12.2 (11.8, 12.5) 36 (28, 40) 911 falling falling trend -4.0 (-5.1, -3.0)
Virginia 6 12.0 (11.7, 12.4) 37 (30, 41) 1,081 falling falling trend -2.4 (-4.6, -1.1)
Alaska 6 11.7 (10.6, 12.9) 38 (24, 46) 87 rising rising trend 1.5 (0.3, 2.9)
Missouri 6 11.7 (11.3, 12.1) 39 (33, 45) 762 falling falling trend -0.9 (-1.4, -0.3)
Michigan 6 11.6 (11.3, 11.9) 40 (36, 45) 1,229 falling falling trend -3.4 (-6.4, -1.3)
Georgia 7 11.5 (11.3, 11.8) 41 (36, 45) 1,269 falling falling trend -2.7 (-4.5, -0.7)
Arkansas 6 11.5 (11.0, 12.1) 42 (32, 46) 370 stable stable trend -1.8 (-5.9, 3.0)
Texas 7 11.5 (11.3, 11.7) 43 (38, 45) 3,293 stable stable trend -0.3 (-1.3, 0.7)
Tennessee 6 11.2 (10.9, 11.6) 44 (38, 46) 817 falling falling trend -2.5 (-4.5, -1.1)
North Carolina 6 11.1 (10.9, 11.4) 45 (40, 46) 1,231 falling falling trend -4.5 (-6.3, -2.8)
District of Columbia 6 9.9 (8.9, 11.0) 46 (40, 49) 73 falling falling trend -6.1 (-9.4, -3.0)
South Carolina 6 9.8 (9.4, 10.2) 47 (46, 48) 545 falling falling trend -3.5 (-4.7, -2.3)
Alabama 6 9.5 (9.1, 9.9) 48 (46, 49) 499 stable stable trend -1.8 (-4.9, 2.1)
Mississippi 6 8.7 (8.2, 9.2) 49 (48, 49) 273 falling falling trend -7.4 (-12.0, -3.9)
Indiana 6
data not available
N/A
data not available
data not available
data not available
Nevada 6
data not available
N/A
data not available
data not available
data not available
Puerto Rico 6 25.6 (24.8, 26.4) N/A 820 falling falling trend -6.0 (-10.1, -1.9)
Notes:
Created by statecancerprofiles.cancer.gov on 06/14/2024 6:02 pm.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana, Nevada, Puerto Rico

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top